Earnings of €1,053 million before interest, taxes and ISE impairment/ Sales revenue down to €2,062 million/ Impairment charge relating to US subsidiary ISE reduces earnings/ Costs below 2009 guidance before impairment/ Expenses for growth initiatives to be increased by more than 50 percent in 2010/ Streamlining of management structure/ Initiatives resolved to reduce annual costs by some €50 million/ Proposed dividend of €2.10 per share for 2009